It has been shown that the inhibition of NF-κB activation can lead to increased Bax expression in some cancer cell lines, such as HCT116, OVCAR-3 and MCF7 cells, but not in HCT15 and MCF7 A/Z cancer cell lines [26]. Here, NFKB1 is linked to cancer.